Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(4.34)
# 369
Out of 5,237 analysts
484
Total ratings
45.71%
Success rate
21.58%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCEL Vericel | Maintains: Buy | $64 | $32.92 | +94.41% | 20 | May 8, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintains: Buy | $150 → $175 | $106.17 | +64.83% | 8 | May 4, 2026 | |
| CELC Celcuity | Upgrades: Buy | $94 → $165 | $125.64 | +31.33% | 12 | May 4, 2026 | |
| CORT Corcept Therapeutics | Maintains: Buy | $60 → $75 | $51.20 | +46.48% | 31 | May 4, 2026 | |
| EVAX Evaxion | Reiterates: Buy | $16 | $4.23 | +278.70% | 16 | Apr 24, 2026 | |
| ACTU Actuate Therapeutics | Reiterates: Buy | $15 | $2.98 | +404.20% | 6 | Apr 22, 2026 | |
| NUVL Nuvalent | Reiterates: Buy | $155 | $104.55 | +48.25% | 6 | Apr 21, 2026 | |
| VOR Vor Biopharma | Maintains: Buy | $32 → $31 | $17.25 | +79.71% | 17 | Apr 15, 2026 | |
| EDAP EDAP TMS | Maintains: Buy | $14 → $10 | $4.17 | +139.81% | 15 | Apr 9, 2026 | |
| RNXT RenovoRx | Reiterates: Buy | $3 | $0.85 | +252.94% | 4 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.42 | +252.11% | 19 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $4.20 | +138.10% | 15 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.48 | +575.68% | 23 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.75 | +154.55% | 12 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $52 | $29.84 | +74.26% | 10 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4.5 → $10 | $6.40 | +56.25% | 9 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.63 | +269.23% | 16 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $2.08 | +92.31% | 16 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $130 | $87.12 | +49.22% | 9 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $18 | $6.61 | +172.31% | 14 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $11.06 | +171.25% | 16 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.87 | +39.37% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $5.78 | +38.41% | 15 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $45 | $14.23 | +216.23% | 14 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $36 | $16.46 | +118.71% | 20 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $5.78 | +124.91% | 19 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $5 | $4.50 | +11.11% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $50 | $3.36 | +1,388.10% | 1 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $22 | $7.95 | +176.73% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $3 | $0.72 | +314.25% | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.39 | +2,696.85% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $2.19 | +584.93% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.00 | +200.00% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.92 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $2.33 | +50.21% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $4.70 | +602.13% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $5.00 | +2,400.00% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.56 | +208.99% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $0.59 | +3,284.09% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $7.68 | +17.19% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.63 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.65 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $0.77 | +3,146.75% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.79 | +31.93% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $3.06 | +3,821.57% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,250 → $1,000 | $4.52 | +22,023.89% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $19.08 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $15.81 | -62.05% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.35 | +1,011.11% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $4.88 | +576.23% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $6.99 | +35.91% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.03 | +1,359,123.30% | 1 | Mar 5, 2020 |
Vericel
May 8, 2026
Maintains: Buy
Price Target: $64
Current: $32.92
Upside: +94.41%
Mirum Pharmaceuticals
May 4, 2026
Maintains: Buy
Price Target: $150 → $175
Current: $106.17
Upside: +64.83%
Celcuity
May 4, 2026
Upgrades: Buy
Price Target: $94 → $165
Current: $125.64
Upside: +31.33%
Corcept Therapeutics
May 4, 2026
Maintains: Buy
Price Target: $60 → $75
Current: $51.20
Upside: +46.48%
Evaxion
Apr 24, 2026
Reiterates: Buy
Price Target: $16
Current: $4.23
Upside: +278.70%
Actuate Therapeutics
Apr 22, 2026
Reiterates: Buy
Price Target: $15
Current: $2.98
Upside: +404.20%
Nuvalent
Apr 21, 2026
Reiterates: Buy
Price Target: $155
Current: $104.55
Upside: +48.25%
Vor Biopharma
Apr 15, 2026
Maintains: Buy
Price Target: $32 → $31
Current: $17.25
Upside: +79.71%
EDAP TMS
Apr 9, 2026
Maintains: Buy
Price Target: $14 → $10
Current: $4.17
Upside: +139.81%
RenovoRx
Apr 8, 2026
Reiterates: Buy
Price Target: $3
Current: $0.85
Upside: +252.94%
Apr 7, 2026
Reiterates: Buy
Price Target: $5
Current: $1.42
Upside: +252.11%
Mar 26, 2026
Maintains: Buy
Price Target: $9 → $10
Current: $4.20
Upside: +138.10%
Mar 25, 2026
Maintains: Buy
Price Target: $7 → $10
Current: $1.48
Upside: +575.68%
Mar 24, 2026
Reiterates: Buy
Price Target: $7
Current: $2.75
Upside: +154.55%
Mar 20, 2026
Maintains: Buy
Price Target: $37 → $52
Current: $29.84
Upside: +74.26%
Mar 19, 2026
Maintains: Buy
Price Target: $4.5 → $10
Current: $6.40
Upside: +56.25%
Mar 13, 2026
Reiterates: Buy
Price Target: $6
Current: $1.63
Upside: +269.23%
Mar 10, 2026
Reiterates: Buy
Price Target: $4
Current: $2.08
Upside: +92.31%
Mar 9, 2026
Maintains: Buy
Price Target: $47 → $130
Current: $87.12
Upside: +49.22%
Jan 26, 2026
Maintains: Buy
Price Target: $25 → $18
Current: $6.61
Upside: +172.31%
Jan 9, 2026
Reiterates: Buy
Price Target: $30
Current: $11.06
Upside: +171.25%
Jan 7, 2026
Initiates: Buy
Price Target: $4
Current: $2.87
Upside: +39.37%
Dec 18, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $5.78
Upside: +38.41%
Dec 2, 2025
Maintains: Buy
Price Target: $70 → $45
Current: $14.23
Upside: +216.23%
Nov 21, 2025
Maintains: Buy
Price Target: $31 → $36
Current: $16.46
Upside: +118.71%
Nov 11, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $5.78
Upside: +124.91%
Nov 10, 2025
Maintains: Buy
Price Target: $3.5 → $5
Current: $4.50
Upside: +11.11%
Nov 4, 2025
Assumes: Buy
Price Target: $50
Current: $3.36
Upside: +1,388.10%
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $7.95
Upside: +176.73%
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $0.72
Upside: +314.25%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $0.39
Upside: +2,696.85%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $2.19
Upside: +584.93%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.00
Upside: +200.00%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.92
Upside: -
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $2.33
Upside: +50.21%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $4.70
Upside: +602.13%
Nov 21, 2024
Reiterates: Buy
Price Target: $125
Current: $5.00
Upside: +2,400.00%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $3.56
Upside: +208.99%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $0.59
Upside: +3,284.09%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $7.68
Upside: +17.19%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.63
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.65
Upside: -
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $0.77
Upside: +3,146.75%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $3.79
Upside: +31.93%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $3.06
Upside: +3,821.57%
Aug 10, 2022
Maintains: Buy
Price Target: $1,250 → $1,000
Current: $4.52
Upside: +22,023.89%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $19.08
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $15.81
Upside: -62.05%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.35
Upside: +1,011.11%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $4.88
Upside: +576.23%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $6.99
Upside: +35.91%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.03
Upside: +1,359,123.30%